Our Philosophy in Partnership
We seek to connect industry, investors, and entrepreneurs with the experts at Children's Hospital Los Angeles to advance science, technology and clinical care. We are here to understand your needs and help guide you through the Hospital’s research enterprise in order for the respective parties to engage in fruitful collaborations.
Research at Children's Hospital Los Angeles spans bench, clinical and community research.
The hospital has 10 core laboratories with specialized personnel and equipment in the fields of genomics, proteomics, cell sorting, and GMP manufacturing to name a few.
Featured Partnerships
CERRX Inc., a Children's Hospital Los Angeles spin off company, grants an exclusive option to Ascalon International Inc., a newly established oncology drug developer, to intravenous (IV) fenretinide (4-HPR) product. Read More.
Hospital enters into an agreement with EntroGen to develop a novel genome-based test for Ewing's Sarcoma. Read more.
Hospital collaborates with the American Type Tissue Culture to make pediatric brain tumor cell lines available for broad distribution to researchers worldwide.
CERRX Inc. secures worldwide exclusive license from Children's Hospital Los Angeles on new formulation of vitamin A analog to treat cancer. Read more.
ICAP Ocean Tomo retained by Children's Hospital Los Angeles / California Institute of Technology to sell patent portfolio relating to non-invasive substance detection technology. Read more.
Agreement Assistance
-
Confidentiality Agreements
-
Corporate Research Funding Agreements
-
Inter-Institutional Agreements
-
License Agreements
-
Material Transfer Agreements
-
Option Agreements
We encourage industry collaborators to contact our office to explore how partnering with us can meet your needs.
|
